- Home
- VZLA vs EBS Comparison
VZLA vs EBS Comparison
Compare VZLA & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VZLA
- EBS
- Stock Information
- Founded
- VZLA 2017
- EBS 1998
- Country
- VZLA Canada
- EBS United States
- Employees
- VZLA N/A
- EBS N/A
- Industry
- VZLA
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- VZLA
- EBS Health Care
- Exchange
- VZLA Nasdaq
- EBS Nasdaq
- Market Cap
- VZLA 448.4M
- EBS 459.6M
- IPO Year
- VZLA N/A
- EBS 2006
- Fundamental
- Price
- VZLA $1.96
- EBS $11.43
- Analyst Decision
- VZLA Strong Buy
- EBS Buy
- Analyst Count
- VZLA 3
- EBS 3
- Target Price
- VZLA $4.33
- EBS $14.00
- AVG Volume (30 Days)
- VZLA 1.3M
- EBS 1.3M
- Earning Date
- VZLA 11-19-2024
- EBS 11-06-2024
- Dividend Yield
- VZLA N/A
- EBS N/A
- EPS Growth
- VZLA N/A
- EBS N/A
- EPS
- VZLA N/A
- EBS N/A
- Revenue
- VZLA N/A
- EBS $1,125,500,000.00
- Revenue This Year
- VZLA N/A
- EBS $6.83
- Revenue Next Year
- VZLA N/A
- EBS $2.50
- P/E Ratio
- VZLA N/A
- EBS N/A
- Revenue Growth
- VZLA N/A
- EBS 2.05
- 52 Week Low
- VZLA $0.96
- EBS $1.42
- 52 Week High
- VZLA $2.40
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- VZLA 44.69
- EBS 66.68
- Support Level
- VZLA $1.88
- EBS $8.66
- Resistance Level
- VZLA $2.06
- EBS $12.73
- Average True Range (ATR)
- VZLA 0.10
- EBS 0.72
- MACD
- VZLA -0.03
- EBS 0.13
- Stochastic Oscillator
- VZLA 21.46
- EBS 60.19
About VZLA Vizsla Silver Corp.
Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.